 | • レポートコード：MRC2-11QY03906 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はナルコレプシー治療薬のグローバル市場について調査・分析したレポートです。種類別（中枢神経刺激薬、オキシベートナトリウム、選択的セロトニン再取り込み阻害薬（SSRI）、三環系抗うつ薬、その他）市場規模、用途別（脱力発作を伴うナルコレプシー、脱力発作を伴わないナルコレプシー、二次ナルコレプシー）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ナルコレプシー治療薬の競争状況、市場シェア ・世界のナルコレプシー治療薬市場：種類別市場規模 2015年-2020年（中枢神経刺激薬、オキシベートナトリウム、選択的セロトニン再取り込み阻害薬（SSRI）、三環系抗うつ薬、その他） ・世界のナルコレプシー治療薬市場：種類別市場規模予測 2021年-2026年（中枢神経刺激薬、オキシベートナトリウム、選択的セロトニン再取り込み阻害薬（SSRI）、三環系抗うつ薬、その他） ・世界のナルコレプシー治療薬市場：用途別市場規模 2015年-2020年（脱力発作を伴うナルコレプシー、脱力発作を伴わないナルコレプシー、二次ナルコレプシー） ・世界のナルコレプシー治療薬市場：用途別市場規模予測 2021年-2026年（脱力発作を伴うナルコレプシー、脱力発作を伴わないナルコレプシー、二次ナルコレプシー） ・北米のナルコレプシー治療薬市場分析：米国、カナダ ・ヨーロッパのナルコレプシー治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのナルコレプシー治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のナルコレプシー治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのナルコレプシー治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Addrenex Pharmaceuticals, Inc.、Teva Pharmaceutical Industries Ltd.、Jazz Pharmaceuticals PLC、Graymark Healthcare, Inc.、Arena Pharmaceuticals, Inc.、BIOPROJET、Takeda、Ligand Pharmaceuticals, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. … These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time.
Market Analysis and Insights: Global Narcolepsy Therapeutics Market
The global Narcolepsy Therapeutics market size is projected to reach US$ 1284.5 million by 2026, from US$ 1184.2 million in 2020, at a CAGR of 7.8%% during 2021-2026.
Global Narcolepsy Therapeutics Scope and Market Size
Narcolepsy Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Narcolepsy Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Addrenex Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals PLC
Graymark Healthcare, Inc.
Arena Pharmaceuticals, Inc.
BIOPROJET
Takeda
Ligand Pharmaceuticals, Inc.
Market segment by Type, the product can be split into
Central nervous system stimulants
Sodium Oxybate
Selective Serotonin Reuptake Inhibitor (SSRI)
Tricyclic Antidepressants
Others
Market segment by Application, split into
Narcolepsy With Cataplexy
Narcolepsy Without Cataplexy
Secondary Narcolepsy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Narcolepsy Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Narcolepsy Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Central nervous system stimulants
1.4.3 Sodium Oxybate
1.4.4 Selective Serotonin Reuptake Inhibitor (SSRI)
1.4.5 Tricyclic Antidepressants
1.4.6 Others
1.5 Market by Application
1.5.1 Global Narcolepsy Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Narcolepsy With Cataplexy
1.5.3 Narcolepsy Without Cataplexy
1.5.4 Secondary Narcolepsy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Narcolepsy Therapeutics Market Perspective (2015-2026)
2.2 Global Narcolepsy Therapeutics Growth Trends by Regions
2.2.1 Narcolepsy Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Narcolepsy Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Narcolepsy Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Narcolepsy Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Narcolepsy Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Narcolepsy Therapeutics Players by Market Size
3.1.1 Global Top Narcolepsy Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Narcolepsy Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Narcolepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Narcolepsy Therapeutics Market Concentration Ratio
3.2.1 Global Narcolepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Narcolepsy Therapeutics Revenue in 2019
3.3 Narcolepsy Therapeutics Key Players Head office and Area Served
3.4 Key Players Narcolepsy Therapeutics Product Solution and Service
3.5 Date of Enter into Narcolepsy Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Narcolepsy Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Narcolepsy Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Narcolepsy Therapeutics Market Size by Application (2015-2020)
5.2 Global Narcolepsy Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Narcolepsy Therapeutics Market Size (2015-2020)
6.2 Narcolepsy Therapeutics Key Players in North America (2019-2020)
6.3 North America Narcolepsy Therapeutics Market Size by Type (2015-2020)
6.4 North America Narcolepsy Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Narcolepsy Therapeutics Market Size (2015-2020)
7.2 Narcolepsy Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Narcolepsy Therapeutics Market Size by Type (2015-2020)
7.4 Europe Narcolepsy Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Narcolepsy Therapeutics Market Size (2015-2020)
8.2 Narcolepsy Therapeutics Key Players in China (2019-2020)
8.3 China Narcolepsy Therapeutics Market Size by Type (2015-2020)
8.4 China Narcolepsy Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Narcolepsy Therapeutics Market Size (2015-2020)
9.2 Narcolepsy Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Narcolepsy Therapeutics Market Size by Type (2015-2020)
9.4 Japan Narcolepsy Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Narcolepsy Therapeutics Market Size (2015-2020)
10.2 Narcolepsy Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Narcolepsy Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Narcolepsy Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Narcolepsy Therapeutics Market Size (2015-2020)
11.2 Narcolepsy Therapeutics Key Players in India (2019-2020)
11.3 India Narcolepsy Therapeutics Market Size by Type (2015-2020)
11.4 India Narcolepsy Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Narcolepsy Therapeutics Market Size (2015-2020)
12.2 Narcolepsy Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Narcolepsy Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Narcolepsy Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Addrenex Pharmaceuticals, Inc.
13.1.1 Addrenex Pharmaceuticals, Inc. Company Details
13.1.2 Addrenex Pharmaceuticals, Inc. Business Overview
13.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
13.1.4 Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2015-2020))
13.1.5 Addrenex Pharmaceuticals, Inc. Recent Development
13.2 Teva Pharmaceutical Industries Ltd.
13.2.1 Teva Pharmaceutical Industries Ltd. Company Details
13.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
13.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Introduction
13.2.4 Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2015-2020)
13.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
13.3 Jazz Pharmaceuticals PLC
13.3.1 Jazz Pharmaceuticals PLC Company Details
13.3.2 Jazz Pharmaceuticals PLC Business Overview
13.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Introduction
13.3.4 Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2015-2020)
13.3.5 Jazz Pharmaceuticals PLC Recent Development
13.4 Graymark Healthcare, Inc.
13.4.1 Graymark Healthcare, Inc. Company Details
13.4.2 Graymark Healthcare, Inc. Business Overview
13.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Introduction
13.4.4 Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2015-2020)
13.4.5 Graymark Healthcare, Inc. Recent Development
13.5 Arena Pharmaceuticals, Inc.
13.5.1 Arena Pharmaceuticals, Inc. Company Details
13.5.2 Arena Pharmaceuticals, Inc. Business Overview
13.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
13.5.4 Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2015-2020)
13.5.5 Arena Pharmaceuticals, Inc. Recent Development
13.6 BIOPROJET
13.6.1 BIOPROJET Company Details
13.6.2 BIOPROJET Business Overview
13.6.3 BIOPROJET Narcolepsy Therapeutics Introduction
13.6.4 BIOPROJET Revenue in Narcolepsy Therapeutics Business (2015-2020)
13.6.5 BIOPROJET Recent Development
13.7 Takeda
13.7.1 Takeda Company Details
13.7.2 Takeda Business Overview
13.7.3 Takeda Narcolepsy Therapeutics Introduction
13.7.4 Takeda Revenue in Narcolepsy Therapeutics Business (2015-2020)
13.7.5 Takeda Recent Development
13.8 Ligand Pharmaceuticals, Inc.
13.8.1 Ligand Pharmaceuticals, Inc. Company Details
13.8.2 Ligand Pharmaceuticals, Inc. Business Overview
13.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
13.8.4 Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2015-2020)
13.8.5 Ligand Pharmaceuticals, Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Narcolepsy Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Narcolepsy Therapeutics Revenue
Table 3. Ranking of Global Top Narcolepsy Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Narcolepsy Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Central nervous system stimulants
Table 6. Key Players of Sodium Oxybate
Table 7. Key Players of Selective Serotonin Reuptake Inhibitor (SSRI)
Table 8. Key Players of Tricyclic Antidepressants
Table 9. Key Players of Others
Table 10. Global Narcolepsy Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Narcolepsy Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Narcolepsy Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Narcolepsy Therapeutics Market Share by Regions (2015-2020)
Table 14. Global Narcolepsy Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Narcolepsy Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Narcolepsy Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Narcolepsy Therapeutics Players
Table 21. Global Narcolepsy Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Narcolepsy Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top Narcolepsy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy Therapeutics as of 2019)
Table 24. Global Narcolepsy Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Narcolepsy Therapeutics Product Solution and Service
Table 27. Date of Enter into Narcolepsy Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Narcolepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Narcolepsy Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global Narcolepsy Therapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Narcolepsy Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global Narcolepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Narcolepsy Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Narcolepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Narcolepsy Therapeutics Market Share (2019-2020)
Table 37. North America Narcolepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Narcolepsy Therapeutics Market Share by Type (2015-2020)
Table 39. North America Narcolepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Narcolepsy Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Narcolepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Narcolepsy Therapeutics Market Share (2019-2020)
Table 43. Europe Narcolepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Narcolepsy Therapeutics Market Share by Type (2015-2020)
Table 45. Europe Narcolepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Narcolepsy Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Narcolepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Narcolepsy Therapeutics Market Share (2019-2020)
Table 49. China Narcolepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Narcolepsy Therapeutics Market Share by Type (2015-2020)
Table 51. China Narcolepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Narcolepsy Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Narcolepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Narcolepsy Therapeutics Market Share (2019-2020)
Table 55. Japan Narcolepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Narcolepsy Therapeutics Market Share by Type (2015-2020)
Table 57. Japan Narcolepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Narcolepsy Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Narcolepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Narcolepsy Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia Narcolepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Narcolepsy Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Narcolepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Narcolepsy Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Narcolepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Narcolepsy Therapeutics Market Share (2019-2020)
Table 67. India Narcolepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Narcolepsy Therapeutics Market Share by Type (2015-2020)
Table 69. India Narcolepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Narcolepsy Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Narcolepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Narcolepsy Therapeutics Market Share (2019-2020)
Table 73. Central & South America Narcolepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Narcolepsy Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Narcolepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Narcolepsy Therapeutics Market Share by Application (2015-2020)
Table 77. Addrenex Pharmaceuticals, Inc. Company Details
Table 78. Addrenex Pharmaceuticals, Inc. Business Overview
Table 79. Addrenex Pharmaceuticals, Inc. Product
Table 80. Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2015-2020) (Million US$)
Table 81. Addrenex Pharmaceuticals, Inc. Recent Development
Table 82. Teva Pharmaceutical Industries Ltd. Company Details
Table 83. Teva Pharmaceutical Industries Ltd. Business Overview
Table 84. Teva Pharmaceutical Industries Ltd. Product
Table 85. Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2015-2020) (Million US$)
Table 86. Teva Pharmaceutical Industries Ltd. Recent Development
Table 87. Jazz Pharmaceuticals PLC Company Details
Table 88. Jazz Pharmaceuticals PLC Business Overview
Table 89. Jazz Pharmaceuticals PLC Product
Table 90. Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2015-2020) (Million US$)
Table 91. Jazz Pharmaceuticals PLC Recent Development
Table 92. Graymark Healthcare, Inc. Company Details
Table 93. Graymark Healthcare, Inc. Business Overview
Table 94. Graymark Healthcare, Inc. Product
Table 95. Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2015-2020) (Million US$)
Table 96. Graymark Healthcare, Inc. Recent Development
Table 97. Arena Pharmaceuticals, Inc. Company Details
Table 98. Arena Pharmaceuticals, Inc. Business Overview
Table 99. Arena Pharmaceuticals, Inc. Product
Table 100. Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2015-2020) (Million US$)
Table 101. Arena Pharmaceuticals, Inc. Recent Development
Table 102. BIOPROJET Company Details
Table 103. BIOPROJET Business Overview
Table 104. BIOPROJET Product
Table 105. BIOPROJET Revenue in Narcolepsy Therapeutics Business (2015-2020) (Million US$)
Table 106. BIOPROJET Recent Development
Table 107. Takeda Company Details
Table 108. Takeda Business Overview
Table 109. Takeda Product
Table 110. Takeda Revenue in Narcolepsy Therapeutics Business (2015-2020) (Million US$)
Table 111. Takeda Recent Development
Table 112. Ligand Pharmaceuticals, Inc. Business Overview
Table 113. Ligand Pharmaceuticals, Inc. Product
Table 114. Ligand Pharmaceuticals, Inc. Company Details
Table 115. Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2015-2020) (Million US$)
Table 116. Ligand Pharmaceuticals, Inc. Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcolepsy Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Central nervous system stimulants Features
Figure 3. Sodium Oxybate Features
Figure 4. Selective Serotonin Reuptake Inhibitor (SSRI) Features
Figure 5. Tricyclic Antidepressants Features
Figure 6. Others Features
Figure 7. Global Narcolepsy Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Narcolepsy With Cataplexy Case Studies
Figure 9. Narcolepsy Without Cataplexy Case Studies
Figure 10. Secondary Narcolepsy Case Studies
Figure 11. Narcolepsy Therapeutics Report Years Considered
Figure 12. Global Narcolepsy Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Narcolepsy Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Narcolepsy Therapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Narcolepsy Therapeutics Market Share by Players in 2019
Figure 17. Global Top Narcolepsy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Narcolepsy Therapeutics Revenue in 2019
Figure 19. North America Narcolepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Narcolepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Narcolepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Narcolepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Narcolepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Narcolepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Narcolepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
ナルコレプシー治療の世界市場（～2026年） Narcolepsy is a chronic neurological disorder that is associated with Excessive Daytime Sleepiness (EDS), hypnagogic hallucinations, cataplexy, sleep paralysis, and fragmented night sleep. By therapeutic treatment, the global narcolepsy treatment market is segmented into central nervous system stimu…- ナルコレプシーの世界市場（～2026年） Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at …
- 産後うつ病治療薬の世界市場（～2026年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
- 産後うつ病治療の世界市場（～2026年） Market Analysis and Insights: Global Postpartum Depression Treatment Market The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Postpartum Depression Treatment Scope and Market Si…
- エネルギーベース治療の世界市場（～2026年） Energy-based therapeutics involves the use of energy fields. Schools Public Buildings Large Warehouse Complexes Hotels increased demand for aesthetic surgeries. Market Analysis and Insights: Global Energy-based Therapeutics Market The global Energy-based Therapeutics market size is projected to reac…